All Updates

All Updates

icon
Filter
Product updates
IQVIA launches AI Assistant to deliver life sciences insights
Clinical Trial Technology
Oct 11, 2024
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Partnerships
Funding
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Clinical Trial Technology

Clinical Trial Technology

Oct 11, 2024

IQVIA launches AI Assistant to deliver life sciences insights

Product updates

  • IQVIA, a provider of clinical research services and healthcare intelligence, has launched the IQVIA AI Assistant, a GenAI technology for life sciences customers. The AI Assistant is a conversational text interface that provides immediate analytic insights.

  • IQVIA AI Assistant offers insights on brand and territory performance, competitive intelligence, and prescription drivers. It is built on IQVIA healthcare-grade AI, which combines high-quality healthcare data with privacy safeguards, validated models for life sciences applications, and expert benchmarking.

  • The company claims that IQVIA AI Assistant significantly reduces the time required to obtain critical information from hours or days to minutes. It is integrated into multiple IQVIA solutions, including Orchestrated Analytics, ChannelDynamics Verbatim, Market Prognosis, and Clinical Data Analytics Solutions.

  • Analyst QuickTake: This marks IQVIA's second product update this year. In June 2024 , the company launched One Home For Sites, a new platform that functions as a unified dashboard for the key systems and tasks required for clinical trials. With the launch of its AI Assistant, the company appears to be bolstering its competitive abilities via product innovation. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.